Biojo Sciences’ CEO to Speak at National Assembly K-Bio Forum

Biojo Sciences is proud to announce that CEO Jenny (Seungyun) Jo will be a keynote speaker at the Korea Biotechnology Strategy Forum, taking place at the National Assembly Building on October 28, 2025. The event is sponsored by Senator Min-hee Choi, Chairman of the National Assembly Standing Committee and Special Committee (Science & Media).

Ms. Jo will discuss key policies and strategic initiatives shaping the future of Korea’s biotechnology, pharmaceutical, and biomanufacturing sectors. Her remarks will focus on overcoming challenges faced by small and medium-sized biotech companies, addressing industry-wide barriers, and advancing policy frameworks that will drive progress toward the K-Bio Vision 2030 goals and beyond.

The forum will be attended by innovative scientists, industry leaders, business executives, government policymakers, and investors, fostering collaboration across sectors to accelerate the growth and global competitiveness of Korea’s biotechnology ecosystem.

Biojo Sciences is a global biopharmaceutical company developing novel clinical-stage therapies that improve patient and family lives. Our approach offers an efficient process by finding and delivering innovative clinical-stage biotechnologies through effective operations. Biojo Sciences U.S. headquarters is located in Bethesda, Maryland, and has a team of experienced biopharma scientists, clinicians, and business professionals who are dedicated to advancing the company’s mission.